CHADDS FORD, Pa., Oct. 22, 2012 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) will announce its third quarter 2012 financial results on Nov. 5, 2012 and will host a conference call and webcast at 8:30 a.m. ET that day to discuss these results.
David P. Holveck, president and CEO of Endo, Julie McHugh, chief operating officer, Dr. Ivan Gergel, executive vice president of R&D, Alan Levin, executive vice president and chief financial officer, and Blaine Davis, senior vice president, corporate affairs will host the call.
Investors and other interested parties may call 866-711-8198 (domestic) or 617-597-5327 (international) and enter passcode 82681027. Please dial in 10 minutes prior to the scheduled start time.
A replay of the call will be available from Nov. 5 at 10:30 a.m. ET until 12:00 p.m. ET on Nov. 19 by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and entering passcode 66955070.A simultaneous webcast of the call may be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 12:00 p.m. ET on Nov. 19. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website. About Endo Endo Health Solutions Inc. (Endo) is a US-based diversified healthcare company that is redefining healthcare value by finding solutions for the unmet needs of patients along care pathways for pain management, pelvic health, urology, endocrinology and oncology. Through our operating companies: AMS, Endo Pharmaceuticals, HealthTronics and Qualitest, Endo is dedicated to improving care through a combination of branded products, generics, devices, technology and services that creates maximum value for patients, providers and payers alike. Learn more at www.endo.com. SOURCE Endo Health Solutions Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts